This page contains a Flash digital edition of a book.
Contents Foreword Jeffrey I Mechanick


Clinical Professor of Medicine and Director of Metabolic Support, Division of Endocrinology, Diabetes, and Bone Diseases, Mount Sinai School of Medicine


Editorial


When Will We Agree on the Origin and Meaning of ‘Wellbeing’? Lewis S Blevins1


and Robert Knutzen2


1. Clinical Professor of Neurological Surgery and Medicine and Medical Director, California Center for Pituitary Disorders, University of San Francisco; 2. President and CEO, Pituitary Network Association


Diabetes Management


Lixisenatide – Once-daily Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes


Celeste C L Quianzon1 and Mansur E Shomali2


1. Senior Fellow in Endocrinology, Diabetes and Metabolism; 2. Program Director, Endocrinology, Diabetes and Metabolism Training Program, Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Union Memorial Hospital


Blood Glucose Monitoring


In Pursuit of an Ideal – A Perspective on Non-invasive Continuous Glucose Monitoring Lisa B English


Director of Scientific and Technological Affairs, C8 MediSensors


Blood Glucose Monitoring in Paediatric Patients – Looking Towards Better Diabetes Management and Perspectives for the Future


William L Clarke


Robert M Blizzard Professor of Pediatric Endocrinology and Chief of Pediatric Endocrinology, Department of Pediatrics, University of Virginia Health Sciences Center


Diabetic Nephropathy


Early Glomerular Filtration Rate Loss as a Marker of Diabetic Nephropathy George Jerums,1


Elif Ekinci,2 Sianna Panagiotopoulos3 and Richard J MacIsaac4


1. Professor, Endocrine Centre, Austin Health and University of Melbourne, Heidelberg Repatriation Hospital; 2. Endocrinologist, Endocrine Centre, Austin Health and University of Melbourne, Heidelberg Repatriation Hospital; 3. Manager, Office for Research, Endocrine Centre, Austin Health and University of Melbourne, Heidelberg Repatriation Hospital; 4. Professor, St Vincent’s Hospital and University of Melbourne


Endothelin Receptor Antagonists in Diabetic Nephropathy René R Wenzel,1


Eberhard Ritz2 and Maximilian Q Wenzel3


1. Head, Department of Internal Medicine, Teaching Hospital, Zell am See; 2. Professor Emeritus, Ruperto Carola University Heidelberg; 3. Medical Student, University of Vienna


Diabetic Macular Oedema


Evidence for Anti-vascular Endothelial Growth Factor Treatment of Diabetic Macular Oedema


Francesco Bandello,1 Umberto De Benedetto,1 Maurizio Battaglia Parodi,1 Maria Lucia Cascavilla1


Karl Anders Knutsson,1 and Pierluigi Iacono2


1.Department of Ophthalmology, Vita-Salute University, San Raffaele Scientific Institute, Milan; 2. GB Bietti Ophthalmology Foundation, Rome


Triamcinolone Acetonide for the Treatment of Diabetic Macular Oedema


Valentina Sarao, Daniele Veritti and Paolo Lanzetta Department of Ophthalmology, University of Udine


4 42 36 32 27 22 18 12 10 8


EUROPEAN ENDOCRINOLOGY


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68